Documents
Application Sponsors
ANDA 090636 | HETERO LABS LTD III | |
Marketing Status
Application Products
001 | TABLET;ORAL | 300MG | 0 | TENOFOVIR DISOPROXIL FUMARATE | TENOFOVIR DISOPROXIL FUMARATE |
FDA Submissions
| ORIG | 1 | AP | 2018-01-26 | |
UNKNOWN; | ORIG | 2 | AP | 2018-01-26 | STANDARD |
LABELING; Labeling | SUPPL | 9 | AP | 2020-01-23 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
HETERO LABS LTD III
cder:Array
(
[0] => Array
(
[ApplNo] => 90636
[companyName] => HETERO LABS LTD III
[docInserts] => ["",""]
[products] => [{"drugName":"TENOFOVIR DISOPROXIL FUMARATE","activeIngredients":"TENOFOVIR DISOPROXIL FUMARATE","strength":"300MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"TENOFOVIR DISOPROXIL FUMARATE","submission":"TENOFOVIR DISOPROXIL FUMARATE","actionType":"300MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)